On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

Uber says it's being taken for a ride by a network of law firms, doctors, and pain-management clinics in New York, accusing them of orchestrating fraudulen ...

New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

The 32nd international conference of the Indian Association of Palliative Care (IAPC) commenced at the All India Institute of Medical Sciences (AIIMS) here on Friday, officials said. Jammu and Kashmir ...

Becker's has reported on three physician practice or clinic closures since Jan. 1: ...